High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.

The purpose of this investigation was to elucidate the association between microvascular blood volume and glucose uptake and to link these measures with tumor angiogenesis. We demonstrate a regionally specific correlation between tumor relative microvascular blood volume (CBV), determined in vivo with functional magnetic resonance imaging techniques, and tumor glucose uptake determined with fluorodeoxyglucose positron emission tomography. Regions of maximum glucose uptake were well matched with maximum CBV across all patients (n = 21; r = 0.572; P = 0.023). High-grade gliomas showed significantly elevated CBV and glucose uptake compared with low-grade gliomas, (P = 0.009 and 0.008, respectively). Correlations between CBV and glucose uptake were then determined on a voxel-by-voxel basis within each patient's glioma. Correlation indices varied widely, but in 16 of 21 cases of human glioma, CBV and glucose uptake were correlated (r > 0.150). These measures were well correlated in all cases when comparing healthy brain tissue in these same patients. Tumor vascularity, as determined immunohistochemically and morphometrically on clinical samples, revealed statistically significant relationships with functional imaging characteristics in vivo. Regional heterogeneities in glucose uptake were well matched with functional magnetic resonance imaging CBV maps. Our findings support the concept that there is an association of microvascular density and tumor energy metabolism in most human gliomas. In addition, the findings are likely to have important clinical applications in the initial evaluation, treatment, and longitudinal monitoring of patients with malignant gliomas.

[1]  B R Rosen,et al.  NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.

[2]  J. Rock,et al.  Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. , 1998, Journal of neurosurgery.

[3]  B. Drayer,et al.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.

[4]  N. Weidner,et al.  Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.

[5]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[6]  S. Goldman,et al.  Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography‐guided stereotactic biopsy , 1996, Cancer.

[7]  H. Heinzl,et al.  Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. , 1996, American journal of clinical pathology.

[8]  J. Arends,et al.  Tumor angiogenesis: an independent prognostic parameter in cervical cancer. , 1996, American journal of obstetrics and gynecology.

[9]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[10]  N. Weidner Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[11]  A. Luxen,et al.  Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. , 1995, Journal of neurosurgery.

[12]  S. Fox,et al.  Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. , 1994, British journal of urology.

[13]  P Okunieff,et al.  Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. , 1994, International journal of radiation oncology, biology, physics.

[14]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[15]  F. Shishido,et al.  Perfusion and metabolism in predicting the survival of patients with cerebral gliomas , 1994, Cancer.

[16]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[17]  C. Streffer Glucose-, energy-metabolism and cell proliferation in tumors. , 1994, Advances in experimental medicine and biology.

[18]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[19]  B. Rosen,et al.  Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.

[20]  B. Rosen,et al.  Functional mapping of the human visual cortex by magnetic resonance imaging. , 1991, Science.

[21]  R. Coleman,et al.  FDG-PET in the selection of brain lesions for biopsy. , 1991, Journal of computer assisted tomography.

[22]  Mark S. Cohen,et al.  Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.

[23]  J M Hoffman,et al.  Clinical application of PET for the evaluation of brain tumors. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  A Gelman,et al.  The Precision of Positron Emission Tomography: Theory and Measurement , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  S. Naber,et al.  Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. , 1991, Cancer research.

[26]  B. Rosen,et al.  Functional Studies of the Human Brain Using High‐speed Magnetic Resonance Imaging , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[27]  B. Rosen,et al.  MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.

[28]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[29]  J. F. Bradshaw,et al.  The principal axes transformation--a method for image registration. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  J W Belliveau,et al.  Functional cerebral imaging by susceptibility‐contrast NMR , 1990, Magnetic resonance in medicine.

[31]  E. Rota Kops,et al.  Performance characteristics of an eight-ring whole body PET scanner. , 1990, Journal of computer assisted tomography.

[32]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[33]  C. B. Shields Leadership in neurosurgery. , 1989, Clinical neurosurgery.

[34]  D. Kennedy,et al.  Magnetic resonance imaging–based brain morphometry: Development and application to normal subjects , 1989, Annals of neurology.

[35]  G. di Chiro,et al.  Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. , 1989, Neurosurgery.

[36]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[37]  Abass Alavi,et al.  Positron emission tomography in patients with glioma a predictor of prognosis , 1988, Cancer.

[38]  C. Kufta,et al.  Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. , 1987, AJR. American journal of roentgenology.

[39]  Alan C. Evans,et al.  Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  P. Gutin,et al.  Differentiation of Cerebral Radiation Necrosis from Tumor Recurrence by [18F]FDG and 82Rb Positron Emission Tomography , 1987, Journal of computer assisted tomography.

[41]  G. Chiro Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[42]  R J Wise,et al.  Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. , 1985, The British journal of radiology.

[43]  C. Bohm,et al.  Correction for Scattered Radiation in a Ring Detector Positron Camera by Integral Transformation of the Projections , 1983, Journal of computer assisted tomography.

[44]  R A Brooks,et al.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography , 1982, Neurology.

[45]  R. Fruchter,et al.  The significance of atypical vessels and neovascularization in cervical neoplasia. , 1981, American journal of obstetrics and gynecology.

[46]  J. Folkman,et al.  Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder , 1980, Annals of surgery.

[47]  J. Folkman,et al.  Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.

[48]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[49]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.